The understanding of idiopathic nephrotic syndrome (INS) is changing. While the majority of children with a steroid-sensitive or steroid-dependent course can be brought into remission with glucocorticoids and further immunosuppression, the steroid-resistant form remains a clinical challenge. The discovery of autoantibodies against the podocytic slit diaphragm protein nephrin opens up a new pathogenetic paradigm. A large multicenter study now shows that anti-nephrin autoantibodies are mainly found in steroid-sensitive and steroid-dependent courses, while they are largely absent in genetically determined or multidrug-resistant forms. This suggests that anti-nephrin antibodies not only reflect pathogenesis and prognosis, but could also guide therapeutic decisions.
Autoren
- Tanja Schliebe
Publikation
- Nephrologie-Special
Related Topics
You May Also Like
- Study report
Long-term data on CFTR modulators in children with cystic fibrosis
- Multiple sclerosis
Multiple sclerosis 2025: New strategies against progression and the role of microglia
- A syndrome between decompensation and chronification
Worsening Heart Failure
- Actinic keratosis
Field-directed therapy methods: what the European guideline recommends
Opicapon: double benefit for motor function and sleep in Parkinson’s disease
- Colorectal cancer
Is exercise better than medication?
- Itching in primary biliary cholangitis
When the skin becomes agony
- TREATswitzerland Register